Neuros Medical, Inc., a medical device company, announced the completion
of their implantable generator for use in chronic pain applications. The
device, named Altius™, delivers their patented high frequency Electrical
Nerve Block™ technology for patients suffering from chronic pain.
Altius(TM) Implantable Generator from Neuros Medical, Inc. (Photo: Business Wire)
Device development was led by Dr. Zi-Ping Fang, Chief Technology Officer
at Neuros Medical. "I am delighted to reach this key milestone of our
technology development," said Dr. Fang. "The Altius System will enable
patients suffering from chronic, intractable pain to utilize a system
which is completely implantable and easy to use."
About one-third the size of an iPhoe®, the rechargeable Altius device
delivers high frequency electrical nerve block technology to a targeted
nerve via an implanted electrode. Patients activate the device with a
small remote control, providing on-demand treatment of a chronic pain
"Dr. Fang and the device development team are to be commended for
outstanding achievement of this important endeavor," stated Jon J.
Snyder, President and CEO of Neuros Medical. "The completion of Altius
sets the stage for safety and efficacy studies to support regulatory
authorization to launch this new therapy," he added.
Neuros Medical is currently conducting a pilot clinical study to
evaluate the Company's patented high frequency Electrical Nerve Block
technology for use in acute treatment of pain in the residual limb of
amputees. The pilot study will complement the positive first-in-man
results in their initial study, where 4 out of 5 patients reported over
50% pain reduction.
About Neuros Medical, Inc.
Neuros Medical, a Cleveland, Ohio based neuromodulation company, is
focused on developing proprietary therapies for unmet needs to patients
worldwide. The Company's patented platform technology, Electrical Nerve
Block™, is focused on the elimination of chronic pain in a variety of
applications including amputation pain, chronic post-surgical pain,
chronic migraine, and trigeminal neuralgia.
* This Press Release is issued by Neuros Medical, Inc. and has
not been authorized, sponsored, or otherwise approved by Apple Inc. The
product name iPhone® is a registered trademark of Apple Inc. for its
mobile digital device. Mention of Apple's iPhone® in this Press Release
is made simply for well-known size comparison purposes to Altius™, a
product designed and developed by Neuros Medical, Inc.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130107005121/en/
[ Back To NFVZone's Homepage ]